Form 8-K ENANTA PHARMACEUTICALS For: Feb 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Enanta Pharma (ENTA) Misses Q1 EPS Views
February 5, 2015 8:13 AM ESTEnanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $2.18, $1.64 worse than the analyst estimate of $3.82. Revenue for the quarter came in at $77.5 million versus the consensus estimate of $84.1 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
... More